Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
39
pubmed:dateCreated
2009-8-17
pubmed:abstractText
To identify an adjuvant that enhances antibody responses in respiratory secretions to inactivated influenza virus vaccine (IVV), a comparison was made of responses to intranasal vaccinations of mice with IVV containing monophosphoryl lipid A (MPL), type I interferon (IFN) or cholera toxin B (CTB). Antibody in nasal secretions and lung wash fluids from mice was increased after vaccination and lung virus was significantly reduced after challenge to a similar level in each adjuvant group. Interferon was selected for a trial in humans. Trivalent inactivated influenza vaccine was given intranasally to healthy adult volunteers alone or with 1 million units (Mu) or 10 Mu of alpha interferon. Vaccinations were well tolerated but neither serum hemagglutination-inhibiting nor neutralizing antibody responses among the vaccine groups were significantly different. Similarly, neither neutralizing nor IgA antibody responses in nasal secretions were significantly different. Thus, despite exhibiting a significant adjuvant effect in mice, interferon did not exhibit an adjuvant effect for induction of antibody in respiratory secretions of humans to inactivated influenza virus vaccine given intranasally.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-10438868, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-10738099, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-10930676, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-11027803, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-11483740, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-11505461, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-11738734, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-11803086, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-12077267, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-12559796, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-15193382, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-15790347, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-16129526, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-16394001, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-16571878, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-16611561, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-16641287, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-17280748, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-17559990, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-17707753, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-18602728, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-2251874, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-4184389, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-4303877, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-4320734, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-4670440, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-6260835, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-6381611, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-6609824, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-6619578, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-7998417, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-8585293, http://linkedlifedata.com/resource/pubmed/commentcorrection/19607949-8852406
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1873-2518
pubmed:author
pubmed:issnType
Electronic
pubmed:day
27
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5344-8
pubmed:dateRevised
2010-9-27
pubmed:meshHeading
pubmed-meshheading:19607949-Adjuvants, Immunologic, pubmed-meshheading:19607949-Administration, Intranasal, pubmed-meshheading:19607949-Adolescent, pubmed-meshheading:19607949-Adult, pubmed-meshheading:19607949-Animals, pubmed-meshheading:19607949-Antibodies, Viral, pubmed-meshheading:19607949-Cholera Toxin, pubmed-meshheading:19607949-Humans, pubmed-meshheading:19607949-Immunity, Mucosal, pubmed-meshheading:19607949-Influenza, Human, pubmed-meshheading:19607949-Influenza A virus, pubmed-meshheading:19607949-Influenza Vaccines, pubmed-meshheading:19607949-Interferon Type I, pubmed-meshheading:19607949-Lipid A, pubmed-meshheading:19607949-Mice, pubmed-meshheading:19607949-Mice, Inbred ICR, pubmed-meshheading:19607949-Neutralization Tests, pubmed-meshheading:19607949-Vaccines, Inactivated, pubmed-meshheading:19607949-Young Adult
pubmed:year
2009
pubmed:articleTitle
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
pubmed:affiliation
Department of Molecular Virology & Microbiology, Baylor College of Medicine, One Baylor Plaza, MS BCM 280, Houston, TX, USA. ikirk@bcm.edu
pubmed:publicationType
Journal Article, Comparative Study
More...